# Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer

> **NCT01116791** · PHASE2 · TERMINATED · sponsor: **Baki Topal** · enrollment: 34 (actual)

## Conditions studied

- Peritoneal Carcinomatosis
- Gastrointestinal Cancer

## Interventions

- **PROCEDURE:** Cytoreductive Surgery (CRS) plus Hyperthermic Intraoperative Peritoneal Chemotherapy with Cisplatin (HIPC)

## Key facts

- **NCT ID:** NCT01116791
- **Lead sponsor:** Baki Topal
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Insufficient enrollment in Pancreatic \& Biliary arm
- **Last updated:** 2015-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01116791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01116791, "Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01116791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*